In vitro interaction between ofloxacin and cefotaxime against gram-positive and gram-negative bacteria involved in serious infections

Chemotherapy

Volumn 44, Issue 2, 1998, Pages 94-98

  Gimeno, C ^a   Borja, J ^b   Navarro, D ^a   Valdes L ^b   Garcia Barbal J ^b   Garcia de Lomas J ^a,b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b Hoechst Marion Roussel ^*  (Spain)

Author keywords

Cefotaxime; In vitro interaction; Ofloxacin

Indexed keywords

CEFOTAXIME; CEPHALOSPORIN DERIVATIVE; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG POTENTIATION; ESCHERICHIA COLI; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; CEFOTAXIME; CEPHALOSPORIN RESISTANCE; CEPHALOSPORINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; DRUG SYNERGISM; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; SPECIES SPECIFICITY;

EID: 0031905224     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007098     Document Type: Article

References (16)

1. Kumada T, Neu HC: In vitro activity of ofloxacin, a quinolone carboxylic acid compared to other quinolones and other antimicrobial agents. J Antimicrob Chemother 1985;16:563-568.
2. Neu HC: Synergy of fluoroquinolones with other antimicrobial agents. Rev Infect Dis 1989; 11(suppl 5):S1025-S1035.
3. Neu HC: Synergy and antagonism of combinations with quinolones. Eur J Clin Microbiol Infect Dis 1991;10: 255-261.
4. Weber P, Boussougnant Y, Farinotti R: Serum bactericidal activity against Enterobacteriaceae producing broad-spectrum β-lactamases in volunteers administered ofloxacin and cefotaxime, alone or combined. Eur J Clin Microbiol Infect Dis 1989;8:524-526.
5. Maiche AG, Teerenhovi L: Empiric treatment of serious infections in patients with cancer: Randomised comparison of two combinations. Infection 1991;19(suppl 6):S326-S329.
6. Jenkins SG, Lewis JW: Synergistic interaction between ofloxacin and cefotaxime against common clinical pathogens. Infection 1995;23:154-162.
7. Smith KR, Pate MS, Cobbs CG, Saag MS: The in vitro effect of ofloxacin alone and in combination with ceftazidime or gentamicin against Pseudomonas aeruginosa; in abstracts of the Fourth International Symposium on New Quinolones, Munich, 1992, p 332.
8. National Committee for Clinical Laboratory Standards: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard, NCCLS Document M7-A3. National Committee for Clinical Laboratory Standards, Villanova, 1993.
9. Eliopoulos GM, Moellering RC: Antimicrobial combinations: in Lorian V (ed): Antibiotics in Laboratory Medicine, ed 3. Baltimore, Williams & Wilkins, 1991, pp 432-492.
10. Chalkley LJ, Koornhof HJ: Antimicrobial activity of ciprofloxacin against Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus determined by the killing curve method: Antibiotic comparisons and synergistic interaction. Antimicrob Agents Chemother 1985; 28:331-342.
11. Farrg NN, Bending JWA, Talboys C, Azadian BS: In vitro study of the activity of ciprofloxacin combined with amikacin or ceftazidime against Pseudomonas aeruginosa. J Antimicrob Chemother 1986;18: 770.
12. Balch LA, Bassey C, Fanciullo G, Smith RP: In vitro antimicrobial activity of enoxacin in combination with eight other antibiotics against Pseudomonas aeruginosa, Enterobacteriaceae, and Staphylococcus aureus. J Antimicrob Chemother 1987;19:45-48.
13. Drugeon HB, Caillon J, Juvin ME, Pirault JL: Dynamics of ceftazidime-pefloxacin interaction shown by a new killing curve checkerboard method. J Antimicrob Chemother 1987;19:187-203.
14. Moody JA, Gerding DN, Peterson LR: Evaluation of ciprofloxacin synergism with other agents by multiple in vitro methods. Am J Med 1987;82:44-54.
15. Thabaut A, Meyran M: Les associations bétalactamines-nouvelles quinolones. Presse Med 1987;16:2167-2171.
16. Eliopoulos GM, Eliopoulos CT: Ciprofloxacin in combination with other antimicrobials. Am J Med 1989;87(suppl 5A):17-22.